Ticker

No recent analyst price targets found for TLTFF.

Latest News for TLTFF

Theralase(R) Releases Q2 2026 Financial Statements

Theralase(R) Provides Updates on its Phase II Bladder Cancer Clinical Study and Oncology Pipeline Toronto, Ontario--(Newsfile Corp. - August 28, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical-stage pharmaceutical company dedicated to the research and development of energy-activated small molecules for the safe and effective destruction of various cancers,…

Newsfile Corp • Aug 28, 2026
Theralase(R) Closes C$3.6 Million Brokered Financing

Toronto, Ontario--(Newsfile Corp. - August 24, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the research and development of energy-activated small molecules for the safe and effective destruction of cancer, bacteria and viruses, is pleased to announce that it has closed its previously announced brokered private…

Newsfile Corp • Aug 24, 2026
Theralase(R) Announces $5 Million Brokered LIFE Offering

Toronto, Ontario--(Newsfile Corp. - August 10, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the research and development of energy-activated small molecules for the safe and effective destruction of cancer, bacteria and viruses is pleased to announce that it has entered into an agreement with Research Capital…

Newsfile Corp • Aug 10, 2026
Theralase(R) Grants Stock Options

Toronto, Ontario--(Newsfile Corp. - August 7, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the research and development of energy-activated small molecules for the safe and effective destruction of cancer, bacteria and viruses, announces the grant of stock options. The Company has granted an aggregate of…

Newsfile Corp • Aug 7, 2026
Theralase(R) Engages Global One Media to Expand Global Investor Awareness

Toronto, Ontario--(Newsfile Corp. - August 4, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the research and development of energy-activated small molecules for the safe and effective destruction of cancer, bacteria and viruses, is pleased to announce that it has engaged Global One Media Group Pte. Ltd. ("Global…

Newsfile Corp • Aug 4, 2026

🧮 Earnings Move Analyzer

Insider Trading

No insider trades found for TLTFF.

No Senate trades found for TLTFF.

No House trades found for TLTFF.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top